verified SJR 0,537 · Q3 • database Scopus / SJR & Web of Science & DOAJ indexed

Switzerland · S. Karger AG

workspace_premium Q3 — Immunology and Allergy lock Subscription · DOAJ

Transfusion Medicine and Hemotherapy

Transfusion Medicine and Hemotherapy is a journal indexed in SJR in Immunology and Allergy and Hematology with an H index of 59. It has an SJR impact factor of 0,537 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,537.

ISSN: 1660-3796

Publisher: S. Karger AG

Category: Immunology and Allergy

Indexation: verifiedScopus / SJR verifiedWeb of Science verifiedDOAJ

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,537 Q3

H-index 59

Acceptance rate pie_chart

31%

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science DOAJ

SJR Impact

0,537

H-index

Docs (year)

Docs 3y

175

Total refs

2510

Cites 3y

310

Citable 3y

151

Cites/Doc 2y

1.73

Ref/Doc

44.04

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Practical Experience of Implementing the INTERCEPT‚Ñ¢ Blood System for Buffy Coat Platelets in a Blood Center

Targeting DNA and RNA in Pathogens: Mode of Action of Amotosalen HCl

Transmission of Hepatitis B Virus 2 Months Prior to Hepatitis Surface Antigen Positivity of Donor Blood

Treatment Options for Autoimmune Cytopenias

Validation of a Pneumatic Post between Two Hospitals for the Transport of Red Cell Concentrates and Blood Samples

Validation of Microbiological Testing of Cellular Medicinal Products Containing Antibiotics

Why 'Safer than Ever' May Not Be Quite Safe Enough

Zu Roth WK: Bericht vom TSE-Meeting <<Safety of Blood Components>>, Frankfurt/M., 21. März 2003>>. Transfus Med Hemother 2003;30:189-193 + Antwort des Autors

Zur Geschichte der Transfusionsmedizin in der ersten Hälfte des 20. Jahrhunderts (unter besonderer Berucksichtigung ihrer Entwicklung in Deutschland)

Transfusionsmedizinische Einrichtungen der Bundeswehr

Protection against Transfusion-Associated Graft-versus-Host Disease in Blood Transfusion: Is Gamma-Irradiation the Only Answer?

Preparative Haemapheresis and Donor Safety

SHOW MORE ARTICLES

Rhesus D Antigenic Determinants on Residual Red Blood Cells in Apheresis and Buffy Coat Platelet Concentrates

Perspectives of Paid Whole Blood and Plasma Donation

Per aspera ad astra: Der lange Weg zum Facharzt fur Transfusionsmedizin

Patient Blood Management Implementation Strategies and Their Effect on Physicians' Risk Perception, Clinical Knowledge and Perioperative Practice - the Frankfurt Experience

Pathophysiology of Alloimmunization

Pathogen Inactivation of Cellular Blood Products -More Security for the Patient or Less?

Ontogeny of the Immune System

Molecular Basis of ABO Variants Including Identification of 16 Novel ABO Subgroup Alleles in Chinese Han Population

Meeting the Challenges of Blood Safety in the 21st Century: Pathogen Inactivation

Management of Autologous Blood Donation in Total Hip Arthroplasty

In vitro Use of Primary Human Hematopoietic Cells as a Model to Investigate the Regulation of Erythropoiesis

IgA Anaphylactic Transfusion Reactions

FAQs

Transfusion Medicine and Hemotherapy has an SJR of 0,537 (best quartile Q3) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Transfusion Medicine and Hemotherapy is 31%.

Transfusion Medicine and Hemotherapy

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Transfusion Medicine and Hemotherapy?

What is the APC / publication cost?

What is the acceptance rate?